《癌癥免疫治療雜志》（JITC）是一本開放的、同行評(píng)議的雜志，出版了腫瘤免疫和癌癥免疫治療的各個(gè)方面，旨在豐富交流，促進(jìn)這一快速發(fā)展領(lǐng)域的科學(xué)理解。感興趣的主題涵蓋基礎(chǔ)科學(xué)轉(zhuǎn)化臨床譜，包括腫瘤宿主相互作用、腫瘤微環(huán)境、動(dòng)物模型、預(yù)測(cè)和預(yù)后免疫生物標(biāo)志物、新型藥物和細(xì)胞療法、疫苗、基于免疫的組合療法以及免疫相關(guān)毒性。

Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy, aiming to enrich communication and advance scientific understanding in this rapidly evolving field. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.